References
- Lucker GP, Happle R, Steijlen PM. An unusual case of porokeratosis involving the natal cleft: porokeratosis ptychotropica? Br J Dermatol. 1995;132:150–151. doi:10.1111/j.1365-2133
- Zhang Z, Li C, Wu F, et al. Genomic variations of the mevalonate pathway in porokeratosis. Elife. 2015;4:e6322. doi:10.7554/eLife.06322
- Liu W, Liu JW, Ma DL. Porokeratosis Ptychotropica. JAMA Dermatol. 2019;155(7):845. doi:10.1001/jamadermatol.2019.0602
- Happle R. Dohi Memorial Lecture. New aspects of cutaneous mosaicism. J Dermatol. 2002;29:681–692. doi:10.1111/j.1346-8138.2002.tb00204.x
- Murase J, Gilliam Anita C. Disseminated superficial actinic porokeratosis co-existing with linear and verrucous porokeratosis in an elderly woman: update on the genetics and clinical expression of porokeratosis. J Am Acad Dermatol. 2010;63:886–891. doi:10.1016/j.jaad.2009.07.038
- Maurizio R, Davide R, Silvia AV, et al. Disseminated superficial actinic porokeratosis following hydroxyurea treatment: a case report. Australas J Dermatol. 2023;64(1):e72–e75. doi:10.1111/ajd.13943
- Atzmony L, Khan Habib M, Lim Young H, et al. Second-Hit, postzygotic PMVK and MVD mutations in linear porokeratosis. JAMA Dermatol. 2019;155:548–555. doi:10.1001/jamadermatol.2019.0016
- Park J, Matralis Alexions N, Berghuis Albert M, et al. Human isoprenoid synthase enzymes as therapeutic targets. Front Chem. 2014;2:e50. doi:10.3389/fchem.2014.00050
- Peng JM, Xiao XM, Chen JW, et al. Novel mutation in MVK gene for co-occurrence of disseminated superficial actinic porokeratosis with porokeratosis ptychotropica. J Dermatol. 2021;48:e137–e139. doi:10.1111/1346-8138.15748
- Xu HJ, Wen GD. Mixed porokeratosis with a novel mevalonate kinase gene mutation: a case report. World J Clin Cases. 2022;10(14):4528–4534.